Shoppers deal keeps paying off for Loblaw

Article Excerpt

LOBLAW COMPANIES LTD. $61 (Toronto symbol L; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 412.5 million; Market cap: $25.2 billion; Price-to-sales ratio: 0.6; Dividend yield: 1.6%; TSINetwork Rating: Above Average; www.loblaw.ca) reported that its sales jumped 49.4% in the three months ended January 3, 2015, to $11.4 billion from $7.6 billion a year earlier. The gain is mainly due to the Shoppers Drug Mart drugstore chain, which Loblaw bought in March 2014. Same-store sales rose 3.3% at Loblaw’s supermarkets and 3.8% at Shoppers. Excluding integration costs and other unusual items, earnings jumped 146.0%, to $396 million from $161 million. Per-share profits gained 68.4%, to $0.96 from $0.57, on more shares outstanding. So far, Loblaw has cut $101 million from its annual costs by eliminating overlapping functions with Shoppers. It expects these savings to reach $300 million a year by 2017. Loblaw is a buy. buy. …